BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 21270828)

  • 1. Complement factor H deficiency and endocapillary glomerulonephritis due to paternal isodisomy and a novel factor H mutation.
    Schejbel L; Schmidt IM; Kirchhoff M; Andersen CB; Marquart HV; Zipfel P; Garred P
    Genes Immun; 2011 Mar; 12(2):90-9. PubMed ID: 21270828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unusual clinical severity of complement membrane cofactor protein-associated hemolytic-uremic syndrome and uniparental isodisomy.
    Fremeaux-Bacchi V; Sanlaville D; Menouer S; Blouin J; Dragon-Durey MA; Fischbach M; Vekemans M; Fridman WH
    Am J Kidney Dis; 2007 Feb; 49(2):323-9. PubMed ID: 17261436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.
    Servais A; Frémeaux-Bacchi V; Lequintrec M; Salomon R; Blouin J; Knebelmann B; Grünfeld JP; Lesavre P; Noël LH; Fakhouri F
    J Med Genet; 2007 Mar; 44(3):193-9. PubMed ID: 17018561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype/phenotype correlations in complement factor H deficiency arising from uniparental isodisomy.
    Wilson V; Darlay R; Wong W; Wood KM; McFarlane J; Schejbel L; Schmidt IM; Harris CL; Tellez J; Hunze EM; Marchbank K; Goodship JA; Goodship TH
    Am J Kidney Dis; 2013 Nov; 62(5):978-83. PubMed ID: 23870792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement factor H deficiency and posttransplantation glomerulonephritis with isolated C3 deposits.
    Boyer O; Noël LH; Balzamo E; Guest G; Biebuyck N; Charbit M; Salomon R; Frémeaux-Bacchi V; Niaudet P
    Am J Kidney Dis; 2008 Apr; 51(4):671-7. PubMed ID: 18371543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models.
    Saunders RE; Abarrategui-Garrido C; Frémeaux-Bacchi V; Goicoechea de Jorge E; Goodship TH; López Trascasa M; Noris M; Ponce Castro IM; Remuzzi G; Rodríguez de Córdoba S; Sánchez-Corral P; Skerka C; Zipfel PF; Perkins SJ
    Hum Mutat; 2007 Mar; 28(3):222-34. PubMed ID: 17089378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete paternal uniparental isodisomy of chromosome 1 resulting in Herlitz junctional epidermolysis bullosa.
    Fassihi H; Wessagowit V; Ashton GH; Moss C; Ward R; Denyer J; Mellerio JE; McGrath JA
    Clin Exp Dermatol; 2005 Jan; 30(1):71-4. PubMed ID: 15663509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic deficiency of complement factor H in a patient with age-related macular degeneration and membranoproliferative glomerulonephritis.
    Montes T; Goicoechea de Jorge E; Ramos R; Gomà M; Pujol O; Sánchez-Corral P; Rodríguez de Córdoba S
    Mol Immunol; 2008 May; 45(10):2897-904. PubMed ID: 18336910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H.
    Pickering MC; Cook HT; Warren J; Bygrave AE; Moss J; Walport MJ; Botto M
    Nat Genet; 2002 Aug; 31(4):424-8. PubMed ID: 12091909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneous pattern of renal disease associated with homozygous factor H deficiency.
    Servais A; Noël LH; Dragon-Durey MA; Gübler MC; Rémy P; Buob D; Cordonnier C; Makdassi R; Jaber W; Boulanger E; Lesavre P; Frémeaux-Bacchi V
    Hum Pathol; 2011 Sep; 42(9):1305-11. PubMed ID: 21396679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis.
    Licht C; Fremeaux-Bacchi V
    Thromb Haemost; 2009 Feb; 101(2):271-8. PubMed ID: 19190809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulse cyclophosphamide therapy and clinical remission in atypical hemolytic uremic syndrome with anti-complement factor H autoantibodies.
    Boyer O; Balzamo E; Charbit M; Biebuyck-Gougé N; Salomon R; Dragon-Durey MA; Frémeaux-Bacchi V; Niaudet P
    Am J Kidney Dis; 2010 May; 55(5):923-7. PubMed ID: 20202729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of compound heterozygous complement factor H mutations on development of atypical hemolytic uremic syndrome-A pedigree revisited.
    Johnson SA; Williams JM; Hakobyan S; Richards A; Perkins SJ; Marchbank KJ; Goodship TH; Morgan BP; Taylor CM; Savage CO
    Mol Immunol; 2010 Apr; 47(7-8):1585-91. PubMed ID: 20304497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene polymorphism of complement factor H in a Turkish patient with membranoproliferative glomerulonephritis type II.
    Sozeri B; Mir S; Berdeli A; Dincel N; Sarsik B
    Iran J Kidney Dis; 2012 Mar; 6(2):149-53. PubMed ID: 22388616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical hemolytic uremic syndrome associated with complement factor H autoantibodies and CFHR1/CFHR3 deficiency.
    Lee BH; Kwak SH; Shin JI; Lee SH; Choi HJ; Kang HG; Ha IS; Lee JS; Dragon-Durey MA; Choi Y; Cheong HI
    Pediatr Res; 2009 Sep; 66(3):336-40. PubMed ID: 19531976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C3 glomerulonephritis associated with a missense mutation in the factor H gene.
    Sugimoto K; Fujita S; Miyazaki K; Okada M; Takemura T
    Tohoku J Exp Med; 2012 Jul; 227(3):211-5. PubMed ID: 22790979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.
    Sellier-Leclerc AL; Fremeaux-Bacchi V; Dragon-Durey MA; Macher MA; Niaudet P; Guest G; Boudailliez B; Bouissou F; Deschenes G; Gie S; Tsimaratos M; Fischbach M; Morin D; Nivet H; Alberti C; Loirat C;
    J Am Soc Nephrol; 2007 Aug; 18(8):2392-400. PubMed ID: 17599974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts.
    Fremeaux-Bacchi V; Kemp EJ; Goodship JA; Dragon-Durey MA; Strain L; Loirat C; Deng HW; Goodship TH
    J Med Genet; 2005 Nov; 42(11):852-6. PubMed ID: 15784724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The decay accelerating factor mutation I197V found in hemolytic uraemic syndrome does not impair complement regulation.
    Kavanagh D; Burgess R; Spitzer D; Richards A; Diaz-Torres ML; Goodship JA; Hourcade DE; Atkinson JP; Goodship TH
    Mol Immunol; 2007 May; 44(12):3162-7. PubMed ID: 17368771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inherited deficiency of membrane cofactor protein expression and varying manifestations of recurrent atypical hemolytic uremic syndrome in a sibling pair.
    Couzi L; Contin-Bordes C; Marliot F; Sarrat A; Grimal P; Moreau JF; Merville P; Fremeaux-Bacchi V
    Am J Kidney Dis; 2008 Aug; 52(2):e5-9. PubMed ID: 18514989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.